Organoid and spheroid tumor models: techniques and applications

S Gunti, ATK Hoke, KP Vu, NR London Jr - Cancers, 2021 - mdpi.com
Simple Summary Cell cultures can be carried out in three dimensions (3D). Organoids and
spheroids are different 3D cell culture models that can be cultured with different techniques …

Predictive validity in drug discovery: what it is, why it matters and how to improve it

JW Scannell, J Bosley, JA Hickman… - Nature Reviews Drug …, 2022 - nature.com
Successful drug discovery is like finding oases of safety and efficacy in chemical and
biological deserts. Screens in disease models, and other decision tools used in drug …

Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

L Ewart, A Apostolou, SA Briggs, CV Carman… - Communications …, 2022 - nature.com
Background Conventional preclinical models often miss drug toxicities, meaning the harm
these drugs pose to humans is only realized in clinical trials or when they make it to market …

[HTML][HTML] High-fidelity drug-induced liver injury screen using human pluripotent stem cell–derived organoids

T Shinozawa, M Kimura, Y Cai, N Saiki, Y Yoneyama… - Gastroenterology, 2021 - Elsevier
Abstract Background & Aims Preclinical identification of compounds at risk of causing drug
induced liver injury (DILI) remains a significant challenge in drug development, highlighting …

Structure-activity relationships of bioactive polysaccharides extracted from macroalgae towards biomedical application: A review

Y Fu, H Jiao, J Sun, CO Okoye, H Zhang, Y Li, X Lu… - Carbohydrate …, 2024 - Elsevier
Macroalgae are valuable and structurally diverse sources of bioactive compounds among
marine resources. The cell walls of macroalgae are rich in polysaccharides which exhibit a …

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

RJ Weaver, EA Blomme, AE Chadwick… - Nature Reviews Drug …, 2020 - nature.com
Drug-induced liver injury (DILI) is a patient-specific, temporal, multifactorial
pathophysiological process that cannot yet be recapitulated in a single in vitro model …

A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications

R **e, V Pal, Y Yu, X Lu, M Gao, S Liang, M Huang… - Biomaterials, 2024 - Elsevier
The limitations of traditional two-dimensional (2D) cultures and animal testing, when it
comes to precisely foreseeing the toxicity and clinical effectiveness of potential drug …

Liver three-dimensional cellular models for high-throughput chemical testing

S Yang, M Ooka, RJ Margolis, M **a - Cell Reports Methods, 2023 - cell.com
Drug-induced hepatotoxicity is a leading cause of drug withdrawal from the market. High-
throughput screening utilizing in vitro liver models is critical for early-stage liver toxicity …

A critical perspective on 3D liver models for drug metabolism and toxicology studies

AS Serras, JS Rodrigues, M Cipriano… - Frontiers in cell and …, 2021 - frontiersin.org
The poor predictability of human liver toxicity is still causing high attrition rates of drug
candidates in the pharmaceutical industry at the non-clinical, clinical, and post-marketing …

3D primary hepatocyte culture systems for analyses of liver diseases, drug metabolism, and toxicity: emerging culture paradigms and applications

VM Lauschke, RZ Shafagh, DFG Hendriks… - Biotechnology …, 2019 - Wiley Online Library
Recent research has shown that the maintenance of relevant liver functions ex vivo requires
models in which the cells exhibit an in vivo‐like phenotype, often achieved by reconstitution …